115 related articles for article (PubMed ID: 22545285)
21. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
[TBL] [Abstract][Full Text] [Related]
22. Paratesticular papillary serous cystadenocarcinoma--a case report.
Kurian RR; Prema NS; Belthazar A
Indian J Pathol Microbiol; 2006 Jan; 49(1):36-7. PubMed ID: 16625973
[TBL] [Abstract][Full Text] [Related]
23. [Histologic diagnosis of endometrial cancer].
Kaku T; Kawano Y; Hagiwara T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
[No Abstract] [Full Text] [Related]
24. Updates in therapy for uterine serous carcinoma.
Roque DM; Santin AD
Curr Opin Obstet Gynecol; 2013 Feb; 25(1):29-37. PubMed ID: 23138439
[TBL] [Abstract][Full Text] [Related]
25. [Two cases of breast cancer, simultaneously associated with uterine cancer].
Saito C; Sagawa T; Negishi H; Begum S; Yamada H; Fujimoto S
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):544-7. PubMed ID: 8754399
[No Abstract] [Full Text] [Related]
26. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
27. High-grade endometrial carcinomas - strategies for typing.
Soslow RA
Histopathology; 2013 Jan; 62(1):89-110. PubMed ID: 23240672
[TBL] [Abstract][Full Text] [Related]
28. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
29. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.
Garg K; Soslow RA
Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830
[TBL] [Abstract][Full Text] [Related]
30. [Can hormone replacement therapy be used following treatment for gynecologic malignancies?].
Gao YL; Zhu JQ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):719-20. PubMed ID: 23159090
[No Abstract] [Full Text] [Related]
31. Contemporary Approaches to High-risk, Early-Stage Serous Endometrial Cancer: Clinical Equipoise Persists.
Bandera C; Dizon DS
Am J Clin Oncol; 2019 Feb; 42(2):107-108. PubMed ID: 29965808
[No Abstract] [Full Text] [Related]
32. IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.
Zhang L; Liu Y; Hao S; Woda BA; Lu D
Am J Surg Pathol; 2011 Jun; 35(6):868-72. PubMed ID: 21566514
[TBL] [Abstract][Full Text] [Related]
33. Controversies in the Management of Early-stage Serous Endometrial Cancer.
Larish A; Mariani A; Langstraat C
In Vivo; 2021; 35(2):671-680. PubMed ID: 33622859
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of p53, MDR-1, and GST-pi expression in endometrial carcinoma].
Todo Y
Hokkaido Igaku Zasshi; 2003 Mar; 78(2):117-27. PubMed ID: 12704854
[No Abstract] [Full Text] [Related]
35. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
[TBL] [Abstract][Full Text] [Related]
36. Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma.
Sakuragi N; Hirai A; Tada M; Yamada H; Yamamoto R; Fujimoto S; Moriuchi T
Gynecol Oncol; 2001 Dec; 83(3):485-90. PubMed ID: 11733960
[TBL] [Abstract][Full Text] [Related]
37. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
[TBL] [Abstract][Full Text] [Related]
38. Fallopian tube carcinoma presenting as an endometrial polyp.
Shveiky D; Anteby SO; Prus D; Rojansky N; Benshushan A; Shushan A
J Obstet Gynaecol; 2007 Feb; 27(2):215-6. PubMed ID: 17454493
[No Abstract] [Full Text] [Related]
39. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.
Jarboe EA; Miron A; Carlson JW; Hirsch MS; Kindelberger D; Mutter GL; Crum CP; Nucci MR
Int J Gynecol Pathol; 2009 Jul; 28(4):308-15. PubMed ID: 19483636
[TBL] [Abstract][Full Text] [Related]
40. High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer.
DuBeshter B; Estler K; Altobelli K; McDonald S; Glantz C; Angel C
Gynecol Oncol; 2004 Aug; 94(2):383-6. PubMed ID: 15297176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
